U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07694310) titled 'Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences' on June 29.
Brief Summary: This study of current or former cancer patients will evaluate the effect of learning about uncertainties with the benefits of a new cancer drug on their hypothetical decisions to take the drug and their perceptions of the drug's effectiveness.
Study Start Date: July 14
Study Type: INTERVENTIONAL
Condition:
Cancer
Intervention:
OTHER: Control
No uncertainty information
OTHER: Unvalidates surrogate endpoint
Zenova has only been shown to shrink the size of tumors. It is unknown whether Zenova improves how patients...